Skip to main content

Instant redemption funds, UPI payments, KYC and more on the MobiKwik App!

Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Regular Payout of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Reg DP until

NAV on August 21, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Total Assets 1,541 cr
Turnover Ratio 65.05%
Expense Ratio 2.28%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: Positive return: 0.63%
  • 1Y: Positive return: 7.63%
  • 3M: Positive return: 5.96%
  • 3Y: Positive return: 18.42%
  • 6M: Positive return: 13.19%
  • 5Y: Positive return: 13.75%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since almost 2 years)
ISIN INF277K017A7
Fund Family Tata
P/E Ratio 42.03
P/B Ratio 6.33
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR

Asset Allocation

  • Equity: 99.1%
  • Debt: 0.9%
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -1.81
Beta 0.99
R-Squared 93.57
Info Ratio -0.59
Tracking Err 4.14
Sortino 1.293
Sharpe 0.788
Std Dev 16.352
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 5.87%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 92.97%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 1.16%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

View Factsheet

-

Best Sector Healthcare Funds

Name Latest NAV Returns 1y   Fund Assets Expense Ratio Risk
597.051 19.12% 5,400 cr 1.02% -
387.340 15.89% 1,371 cr 1.28% -
47.270 8.59% 6,803 cr 1.33% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata